| Date: Nov 3, 2009
|  |
Primary care physicians' recommendations for Papanicolaou testing are less likely to be in line with cervical cancer screening guidelines, according to a cross-sectional survey published in the Nov. 3 issue of the Annals of Internal Medicine.
Date: Oct 27, 2009
| 
|
Liquid-based cytology has no better sensitivity or specificity than conventional cytology for detection of cervical cancer precursors, according to a study in the Oct. 28 issue of Journal of the American Medical Association.
Date: Oct 23, 2009
| 
|
Pregnancies in women with cancer tend to have good outcomes overall, but have been associated with high rates of induced labor and newborn admission to a neonatal intensive care unit, according to a study published online Oct. 19 in the Journal of Clinical Oncology.
Date: Oct 21, 2009
| 
|
Giving human papillomavirus vaccinations to older women may provide little absolute risk reduction at a high cost, according to a study in the Oct. 20 issue of the Annals of Internal Medicine.
Date: Oct 19, 2009
| 
|
On Oct. 16, the U.S. Food and Drug Administration approved two vaccines to prevent diseases related to human papillomavirus in males and females.
Date: Oct 13, 2009
| 
|
Uterine papillary serous carcinoma, the less common form of endometrial cancer, causes a disproportionate number of deaths, and more clinical trials are needed to develop evidence-based management strategies, according to a literature review in the October issue of Gynecologic Oncology.
Date: Oct 12, 2009
| 
|
Human papillomavirus types -16 and -18 are common in north Indian women with cervical cancer or an unhealthy cervix, and a cervical cancer vaccine targeting these types could eliminate 75 percent of the region's cervical cancers, according to a study presented at the American Association for Cancer Research Frontiers in Basic Cancer Research Meeting, held from Oct. 8 to 11 in Boston.
Date: Oct 12, 2009
| 
|
Immunodeficiency greatly increases the risk of seven AIDS-defining and non-AIDS-defining cancers in HIV-infected patients, and combination treatment that increases CD4 counts can reduce this risk, according to a study published online Oct. 8 in The Lancet Oncology.
|
|